Market Research Report
North America Proteomics Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||823178|
|Published||Content info||126 Pages
Delivery time: 2-3 business days
|North America Proteomics Market Forecast 2019-2027|
|Published: April 15, 2019||Content info: 126 Pages||
The Proteomics market in North America is significantly driven by the advancement in proteomic technologies, increase in R&D expenditure, the technological advancements and the increasing use of proteomics information in various fields. The global proteomics market by North America is anticipated to generate revenue of $XX billion by 2027 and to grow at a CAGR of 13.64% between 2019 and 2027.
North American market comprises the U.S. and Canada. The U.S. proteomics market is expected to account for the majority share in the global market. A large number of significant developments have shaped the North America proteomics industry. The North America region has a large life science infrastructure of pharmaceutical and biotechnology companies.
The proteomics research received a major boost in Canada, owing to the multiple funding support by a government organization. The market witnessed significant growth, owing to heavy funding by various organizations and increase in adoption of agreements & collaborations. Moreover, the rise in R&D investments is anticipated to facilitate the market growth. However, recent economic tensions in the region are anticipated to affect the growth rate negatively.
The major market players operating in the region are Waters Corporation, PerkinElmer, Inc., LI-COR Inc., Agilent Technologies, Inc., Bruker Corporation, Caprion Biosciences (acquired by GHO Capital), Qiagen N.V., Luminex Corp., Merck & Company Inc., Danaher Corporation, Horiba, Ltd., GlaxoSmithKline, General Electric Company, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific Inc. They are exhaustively profiled in the report.